Kazia Therapeutics (KZIA) Return on Sales (2011 - 2017)

Kazia Therapeutics' Return on Sales history runs 6 years deep, the most recent figure standing at 0.01% for Q2 2017.

• Quarterly Return on Sales rose 2.0% year-over-year to 0.01% in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 0.02% (changed 0.0% YoY) and the FY2025 annual result came in at 4.93%, down 481.0% from the prior year.
• Return on Sales was 0.01% for Q2 2017 at Kazia Therapeutics, up from 0.03% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q4 2013 and bottomed at 0.03% in Q2 2016.
• A 4-year average of 0.02% and a median of 0.03% in 2015 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2013 — Return on Sales changed 0 bps — and 2017, when it grew 2 bps.
• Kazia Therapeutics' Return on Sales stood at 0.01% in 2013, then plunged by 195 bps to 0.03% in 2015, then fell by 16 bps to 0.03% in 2016, then jumped by 58 bps to 0.01% in 2017.
• Business Quant data shows KZIA's Return on Sales at 0.01% in Q2 2017, 0.03% in Q4 2016, and 0.03% in Q2 2016.